BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2025 10:33:53 AM | Browse: 42 | Download: 161
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 101991
Country China
Received
2024-10-04 07:12
Peer-Review Started
2024-10-04 07:12
To Make the First Decision
Return for Revision
2024-11-10 08:16
Revised
2024-11-21 07:44
Second Decision
2025-01-08 02:37
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-01-08 07:55
Articles in Press
2025-01-08 07:55
Publication Fee Transferred
2024-12-16 03:49
Edit the Manuscript by Language Editor
2025-01-14 02:29
Typeset the Manuscript
2025-01-21 02:45
Publish the Manuscript Online
2025-02-14 10:33
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Immunology
Manuscript Type Basic Study
Article Title Irreversible electroporation combined with anti-programmed cell death protein 1 therapy promotes tumor antigen-specific CD8+ T cells response
Manuscript Source Unsolicited Manuscript
All Author List Yang-Yang Ma, Xiao-Hua Wang, Jian-Ying Zeng, Ji-Bing Chen and Li-Zhi Niu
ORCID
Author(s) ORCID Number
Yang-Yang Ma http://orcid.org/0000-0003-0092-963X
Li-Zhi Niu http://orcid.org/0000-0002-8808-0978
Funding Agency and Grant Number
Funding Agency Grant Number
Science and Technology Program of Guangzhou 202102010077
International Science Foundation of Guangzhou Fuda Cancer Hospital Y2020-ZD-03
Corresponding Author Li-Zhi Niu, Chief Physician, MD, PhD, Department of Oncology, Guangzhou Fuda Cancer Hospital, No. 2 Tangde West Road, Tianhe District, Guangzhou 510665, Guangdong Province, China. niuboshi@fudahospital.com
Key Words Irreversible electroporation; Pancreatic cancer; Programmed cell death protein 1 blockade; CD8+ T cell; Anticancer immunity
Core Tip This study highlights the synergistic effect of combining irreversible electroporation with anti-programmed cell death protein 1 therapy in the treatment of subcutaneous pancreatic cancer. The combination significantly enhances T lymphocyte infiltration, elevates key cytokine levels, and promotes CD8+ T cell-mediated immune responses, resulting in a marked reduction in tumor volume. These findings suggest a promising avenue for improving immunotherapy strategies in pancreatic cancer through enhanced local tumor ablation methods.
Publish Date 2025-02-14 10:33
Citation <p>Ma YY, Wang XH, Zeng JY, Chen JB, Niu LZ. Irreversible electroporation combined with anti-programmed cell death protein 1 therapy promotes tumor antigen-specific CD8+ T cells response. <i>World J Gastrointest Oncol</i> 2025; 17(3): 101991</p>
URL https://www.wjgnet.com/1948-5204/full/v17/i3/101991.htm
DOI https://dx.doi.org/10.4251/wjgo.v17.i3.101991
Full Article (PDF) WJGO-17-101991-with-cover.pdf
The ARRIVE Guidelines 101991-The-ARRIVE-Guidelines.pdf
Manuscript File 101991_Auto_Edited_083734.docx
Answering Reviewers 101991-answering-reviewers.pdf
Audio Core Tip 101991-audio.mp3
Biostatistics Review Certificate 101991-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form 101991-conflict-of-interest-statement.pdf
Copyright License Agreement 101991-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 101991-foundation-statement.pdf
Institutional Animal Care and Use Committee Approval Form or Document 101991-institutional-animal-care-and-use-committee-statement.pdf
Non-Native Speakers of English Editing Certificate 101991-non-native-speakers.pdf
Peer-review Report 101991-peer-reviews.pdf
Scientific Misconduct Check 101991-scientific-misconduct-check.png
Scientific Editor Work List 101991-scientific-editor-work-list.pdf
CrossCheck Report 101991-crosscheck-report.png
CrossCheck Report 101991-crosscheck-report.pdf